Researchers from Ohio State University in Columbus have recently conducted a study in mice, investigating a new cellular target with the potential to prevent inflammation following traumatic brain injury.
More specifically, they tested a drug that allowed them to block the activity of microglia, a type of nerve cell with a key role in the immune response.
“We used a drug to wipe out cells called microglia in mice that had experienced brain injury, and the inflammation that is a hallmark of traumatic brain injury vanished,” explains lead researcher Kristina Witcher.
